Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 25496487)

Published in Ann Am Thorac Soc on January 01, 2015

Authors

Michael A Puskarich1, Michael A Finkel, Alla Karnovsky, Alan E Jones, Julie Trexel, Brooke N Harris, Kathleen A Stringer

Author Affiliations

1: 1 Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi.

Articles cited by this

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00

A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05

Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA (2010) 8.09

The human serum metabolome. PLoS One (2011) 5.55

Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (2002) 4.42

Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature (2006) 3.45

Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med (2008) 3.14

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01

Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock. Crit Care Med (2014) 2.97

Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem (2009) 2.28

An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med (2013) 2.23

Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA (2014) 2.23

Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics (2012) 2.18

The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol (2011) 2.02

The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med (2011) 2.02

Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med (2000) 1.83

New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol (2007) 1.67

Role of carnitine in disease. Nutr Metab (Lond) (2010) 1.63

Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med (2007) 1.58

Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion (2004) 1.56

Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Anal Biochem (2008) 1.51

Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury. J Crit Care (2008) 1.43

Alterations of mitochondrial function in sepsis and critical illness. Curr Opin Anaesthesiol (2009) 1.30

Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol (2010) 1.21

Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis. Pharmacogenomics J (2012) 1.15

A view from above: cloud plots to visualize global metabolomic data. Anal Chem (2012) 1.15

Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clin Pharmacol Ther (2013) 1.11

Obesity and lipid stress inhibit carnitine acetyltransferase activity. J Lipid Res (2014) 1.10

Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics. Clin Pharmacol Ther (2013) 1.10

Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets (2009) 1.09

Momentum grows to make 'personalized' medicine more 'precise'. Nat Med (2013) 1.07

Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra. J Biomol NMR (2011) 1.00

Clinical metabolomics paves the way towards future healthcare strategies. Br J Clin Pharmacol (2013) 0.95

Quantitative analysis in magnetic resonance spectroscopy: from metabolic profiling to in vivo biomarkers. Bioanalysis (2012) 0.95

Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy. Clin Pharmacol Ther (2013) 0.93

Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med (2013) 0.91

The beginning of personalized medicine in sepsis: small steps to a bright future. Clin Genet (2014) 0.89

Pharmacometabonomics and personalized medicine. Ann Clin Biochem (2013) 0.89

Carnitines and its congeners: a metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci (2004) 0.84

Lactate clearance for assessing response to resuscitation in severe sepsis. Acad Emerg Med (2013) 0.84

Influence of acetyl-L-carnitine infusion on haemodynamic parameters and survival of circulatory-shock patients. Int J Clin Pharmacol Res (1991) 0.83

Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: a randomized control trial. JPEN J Parenter Enteral Nutr (2013) 0.81

Signal intensities derived from different NMR probes and parameters contribute to variations in quantification of metabolites. PLoS One (2014) 0.81

Septic ketoacidosis. Intern Med (2014) 0.80

Update in sepsis and pulmonary infections 2013. Am J Respir Crit Care Med (2014) 0.78

Metabolic flexibility and carnitine flux: The role of carnitine acyltransferase in glucose homeostasis. J Diabetes Investig (2013) 0.76

Effects of L-carnitine administration on mitochondrial electron transport activity present in human muscle during circulatory shock. Int J Clin Pharmacol Res (1985) 0.76

Articles by these authors

The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med (2015) 6.00

Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA (2010) 4.37

Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med (2011) 3.82

Significance of arterial hypotension after resuscitation from cardiac arrest. Crit Care Med (2009) 2.68

Relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest. Circulation (2011) 2.65

Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock (2009) 2.59

Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med (2011) 2.30

Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock. Chest (2013) 2.20

Prospective study of the diagnostic accuracy of the simplify D-dimer assay for pulmonary embolism in emergency department patients. Chest (2006) 2.14

ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics (2009) 2.11

Use of goal-directed therapy for severe sepsis and septic shock in academic emergency departments. Crit Care Med (2005) 2.03

The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med (2011) 2.02

Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation (2011) 1.87

A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore. Proc Natl Acad Sci U S A (2009) 1.82

Incidence and factors associated with cardiac arrest complicating emergency airway management. Resuscitation (2013) 1.77

Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol (2009) 1.74

The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care (2010) 1.72

Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics (2011) 1.69

Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics (2010) 1.62

Multicenter study of central venous oxygen saturation (ScvO(2)) as a predictor of mortality in patients with sepsis. Ann Emerg Med (2009) 1.62

Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock (2011) 1.61

Immediate complications of intravenous contrast for computed tomography imaging in the outpatient setting are rare. Acad Emerg Med (2011) 1.59

One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care (2009) 1.57

Simple triage scoring system predicting death and the need for critical care resources for use during epidemics. Crit Care Med (2007) 1.44

Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis (2010) 1.44

Arterial blood pressure and neurologic outcome after resuscitation from cardiac arrest*. Crit Care Med (2014) 1.43

Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes? Ann Emerg Med (2012) 1.38

Impact of a rapid rule-out protocol for pulmonary embolism on the rate of screening, missed cases, and pulmonary vascular imaging in an urban US emergency department. Ann Emerg Med (2004) 1.34

Point: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? Yes. Chest (2011) 1.33

Electronic medical record review as a surrogate to telephone follow-up to establish outcome for diagnostic research studies in the emergency department. Acad Emerg Med (2005) 1.32

The impact of emergency medical services on the ED care of severe sepsis. Am J Emerg Med (2010) 1.30

Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med (2012) 1.24

Demographic characteristics and estimated prevalence of Fontan-associated plastic bronchitis. Pediatr Cardiol (2012) 1.23

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J (2003) 1.21

Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol (2010) 1.21

Prospective, longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator. Pediatr Cardiol (2011) 1.19

Biomarkers of endothelial cell activation in early sepsis. Shock (2013) 1.18

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15

The effect of etomidate on mortality in sepsis remains unclear. Crit Care Med (2013) 1.12

Quantitative organellar proteomics analysis of rough endoplasmic reticulum from normal and acute pancreatitis rat pancreas. J Proteome Res (2010) 1.11

Future clinical pharmacy practitioners should be board-certified specialists. Pharmacotherapy (2006) 1.09

The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care (2011) 1.09

Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response. Antimicrob Agents Chemother (2012) 1.07

Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 1.06

Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography. Acad Emerg Med (2012) 1.04

Predictors of the complication of postintubation hypotension during emergency airway management. J Crit Care (2012) 1.02

Randomized trial of computerized quantitative pretest probability in low-risk chest pain patients: effect on safety and resource use. Ann Emerg Med (2009) 1.00

Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. J Proteome Res (2013) 1.00

LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types. BMC Genomics (2012) 0.99

Prospective study of the clinical features and outcomes of emergency department patients with delayed diagnosis of pulmonary embolism. Acad Emerg Med (2007) 0.98

Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway casts. Ann Am Thorac Soc (2013) 0.98

The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Med (2009) 0.97

Comparison of the unstructured clinician estimate of pretest probability for pulmonary embolism to the Canadian score and the Charlotte rule: a prospective observational study. Acad Emerg Med (2005) 0.97

Outcomes of trauma victims with cardiac arrest who survive to intensive care unit admission. J Trauma (2011) 0.97

Multicenter observational study of the development of progressive organ dysfunction and therapeutic interventions in normotensive sepsis patients in the emergency department. Acad Emerg Med (2013) 0.97

The frequency and significance of postintubation hypotension during emergency airway management. J Crit Care (2011) 0.97

Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. Resuscitation (2008) 0.96

Complement activation in emergency department patients with severe sepsis. Acad Emerg Med (2010) 0.94

Diabetes is not associated with increased mortality in emergency department patients with sepsis. Ann Emerg Med (2011) 0.92

Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome. Pharmacotherapy (2007) 0.92

Characteristics and outcomes of patients with vasoplegic versus tissue dysoxic septic shock. Shock (2013) 0.91

Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Thromb Res (2012) 0.90

Feasibility of tissue plasminogen activator formulated for pulmonary delivery. Pharm Res (2005) 0.90

Plasma levels of mitochondrial DNA in patients presenting to the emergency department with sepsis. Shock (2012) 0.89

Regionalization of post-cardiac arrest care: implementation of a cardiac resuscitation center. Am Heart J (2012) 0.89

Molecular characterization of the endoplasmic reticulum: insights from proteomic studies. Proteomics (2010) 0.88

Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in mice. Pulm Pharmacol Ther (2009) 0.86

Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancer. J Thorac Oncol (2013) 0.85

Metab2MeSH: annotating compounds with medical subject headings. Bioinformatics (2012) 0.85

Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury. Am J Respir Cell Mol Biol (2012) 0.85

Evidence-based therapies for sepsis care in the emergency department: striking a balance between feasibility and necessity. Acad Emerg Med (2005) 0.85

Discordance between microcirculatory alterations and arterial pressure in patients with hemodynamic instability. J Crit Care (2012) 0.84

N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography. Ann Emerg Med (2013) 0.84

Inhibition of human neutrophil reactive oxygen species production and p67phox translocation by cigarette smoke extract. Atherosclerosis (2005) 0.84

Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease. Pharmacotherapy (2013) 0.84

Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis. J Clin Pharmacol (2009) 0.84

Chemical Analysis of Drug Biocrystals: A Role for Counterion Transport Pathways in Intracellular Drug Disposition. Mol Pharm (2015) 0.84

An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success. Crit Care Med (2013) 0.83

Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion. Mol Pharm (2015) 0.83

Tenecteplase to treat pulmonary embolism in the emergency department. J Thromb Thrombolysis (2007) 0.82

Dynamics of human complement-mediated killing of Klebsiella pneumoniae. Am J Respir Cell Mol Biol (2009) 0.82

Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes. Emerg Med Australas (2013) 0.82

A cell-based computational modeling approach for developing site-directed molecular probes. PLoS Comput Biol (2012) 0.81

Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics. Shock (2015) 0.81

Early goal-directed therapy: improving mortality and morbidity of sepsis in the emergency department. Jt Comm J Qual Patient Saf (2009) 0.81

Accuracy of trauma ultrasound in major pelvic injury. J Trauma (2006) 0.81

The etomidate debate. Ann Emerg Med (2010) 0.79

Prognostic value of incremental lactate elevations in emergency department patients with suspected infection. Acad Emerg Med (2012) 0.79

Multicenter, randomized trial of quantitative pretest probability to reduce unnecessary medical radiation exposure in emergency department patients with chest pain and dyspnea. Circ Cardiovasc Imaging (2013) 0.79

Microarray analysis identifies IL-1 receptor type 2 as a novel candidate biomarker in patients with acute respiratory distress syndrome. Respir Res (2015) 0.79

Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism. J Thromb Thrombolysis (2015) 0.79

Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock? Ann Emerg Med (2013) 0.79

Impact of a critical pathway on acute myocardial infarction quality indicators. Pharmacotherapy (2004) 0.79

Is lactate the "Holy Grail" of biomarkers for sepsis prognosis? Crit Care Med (2009) 0.79

Explicitly targeting explicit sepsis: fair metrics for quality assessment*. Crit Care Med (2014) 0.78

Outcome measures utilized in clinical trials of interventions for post-cardiac arrest syndrome: a systematic review. Resuscitation (2009) 0.78